ADVIA CENTAUR TROPONIN ULTRA (TNI-ULTRA) ASSAY
Report
- Report Number
- 1219913-2014-00265
- Event Type
- Malfunction
- Date Received
- October 24, 2014
- Date of Event
- October 13, 2014
- Report Date
- October 17, 2014
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS, INC.
- Product Code
- MMI
- PMA / PMN Number
- K053020
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE CAUSE FOR THE DISCORDANT TROPONIN ULTRA RESULTS IS UNKNOWN. A SIEMENS CUSTOMER SERVICE ENGINEER (CSE) WAS SENT TO THE CUSTOMER SITE FOR SYSTEM INSPECTION. INSPECTION IN PROCESS. THE INSTRUCTION FOR USE UNDER THE SUMMARY AND EXPLANATION OF THE TEST SECTION STATES THE FOLLOWING: "ALWAYS ANALYZE CTNI RESULTS IN THE CONTEXT OF TIME ELAPSED SINCE PATIENT PRESENTATION TO THE HOSPITAL. SERIAL SAMPLING IS RECOMMENDED TO DETECT THE TEMPORAL RISE AND FALL OF TROPONIN LEVELS CHARACTERISTIC OF MI. IN ACCORD WITH PUBLISHED RECOMMENDATIONS, SERIAL TESTING OF CTNI AT INTERVALS OF 2 TO 4 HOURS FOR UP TO 12 TO 24 HOURS IS SUGGESTED TO CORROBORATE A SINGLE CTNI RESULT. AN ELEVATED TROPONIN ALONE IS NOT SUFFICIENT TO MAKE THE DIAGNOSIS OF MI. OTHER MARKERS, SUCH AS CK-MB AND MYOGLOBIN, CAN BE USED IN CONJUNCTION WITH CTNI RESULTS IN AIDING THE DIAGNOSIS OF MI."
SIEMENS FILED THE INITIAL MDR 1219913-2014-00265 ON OCTOBER 24, 2014. ON 01/06/2015 ADDITIONAL INFORMATION: A CUSTOMER SERVICE ENGINEER (CSE ) WAS SENT TO THE CUSTOMER SITE FOR SYSTEM INSPECTION. THE CSE REPLACED THE VALVE MANIFOLD IN DISPENSE PORT 3 ON THE ADVIA CENTAUR SN: (B)(4). THE IMPRECISION WITH REAGENT LOT 010086 WAS RESOLVED. THE CUSTOMER WAS PROVIDED WITH TROPONIN ULTRA REAGENT LOT # 010087 FOR TROUBLESHOOTING. THERE WERE NO PRECISION ISSUES OBSERVED WITH REAGENT LOT 010087. THE REAGENT LOT 010087 MET THE CUSTOMER'S EXPECTATIONS. THE INSTRUMENT IS PERFORMING ACCORDING TO SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.
IMPRECISE ADVIA CENTAUR TROPONIN ULTRA (TNI-ULTRA) RESULTS WERE OBTAINED ON TWENTY FIVE PATIENT SAMPLES DURING A METHOD EVALUATION OF REAGENT LOT # 010086. NO RESULTS WERE REPORTED TO PHYSICIANS. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT TROPONIN ULTRA RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 679144 | ADVIA CENTAUR TROPONIN ULTRA (TNI-ULTRA) ASSAY | TROPONIN IMMUNOASSAY | MMI | SIEMENS HEALTHCARE DIAGNOSTICS, INC. | N/A | 010086 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |